価格表

在庫・価格 : 2024年05月24日 21時31分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Activin B, Human, Recombinant
データシート
659-AB-025 RSDアールアンドディー システムス
R&D Systems, Inc.
25 μg ¥199,000
(未発注)
追加

在庫・価格 : 2024年05月24日 21時31分 現在

Activin B, Human, Recombinant

  • 商品コード:659-AB-025
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥199,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 van Eyll JM et al. Shh-dependent differentiation of intestinal tissue from embryonic pancreas by activin A. J. Cell. Sci. 2004 Apr;117(Pt 10):2077-86
van Eyll JM et al
2004/01/01
Application: Bioassay, Sample Type: N/A PubMed
2 Farnworth PG et al. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins. J. Endocrinol. 2006 Mar;188(3):451-65
Farnworth PG et al
2006/01/01
Species: Mouse, Application: Competitive Binding Assay, Sample type: Whole Cells PubMed
3 Maeshima A et al. Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct. Dev. Biol. 2006 Jul;295(2):473-85
Maeshima A et al
2006/01/01
Species: Rat, Application: Bioassay, Sample type: Whole Tissue PubMed
4 Farnworth PG et al. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan. Endocrinology 2007 Nov;148(11):5355-68
Farnworth PG et al
2007/01/01
Species: Mouse, Application: Competitive Binding Assay, Sample type: Whole Cells PubMed
5 Kupershmidt L et al. The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases. J. Neurochem. 2007 Nov;103(3):962-71
Kupershmidt L et al
2007/01/01
Species: Human, Application: Bioassay, Western Blot Control, Sample type: Whole Cells PubMed
6 Watanabe K et al. Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor. J. Biol. Chem. 2007 Dec;282(49):35772-86
Watanabe K et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
7 Wacker I et al. Key role for activin B in cellular transformation after loss of the von Hippel-Lindau tumor suppressor. Mol. Cell. Biol. 2009 Apr;29(7):1707-18
Wacker I et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Castonguay R et al. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J. Biol. Chem. 2011 Aug;286(34):30034-46
Castonguay R et al
2011/01/01
Application: Surface Plasmon Resonance, Sample Type: recombinant Endoglin PubMed
9 Mottershead DG et al. Signalling pathways mediating specific synergistic interactions between GDF9 and BMP15. Mol. Hum. Reprod. 2012 Mar;18(3):121-8
Mottershead DG et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
10 Kadaja M et al. SOX9: a stem cell transcriptional regulator of secreted niche signaling factors. Genes Dev. 2014 Feb;28(4):328-41
Kadaja M et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
11 Carrancio S et al. An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin. Br. J. Haematol. 2014 Jun;165(6):870-82
Carrancio S et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Tamminen JA et al. Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. Exp. Cell Res. 2015 Mar;332(1):102-15
Tamminen JA et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
13 Ungefroren H et al. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
Ungefroren H et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
14 Kanamori Y et al. Regulation of hepcidin expression by inflammation-induced activin B. Sci Rep 2016 Dec;6:38702
Kanamori Y et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    van Eyll JM et al. Shh-dependent differentiation of intestinal tissue from embryonic pancreas by activin A. J. Cell. Sci. 2004 Apr;117(Pt 10):2077-86
    van Eyll JM et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Farnworth PG et al. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins. J. Endocrinol. 2006 Mar;188(3):451-65
    Farnworth PG et al
    2006/01/01
  • 備考:
    Species: Mouse, Application: Competitive Binding Assay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Maeshima A et al. Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct. Dev. Biol. 2006 Jul;295(2):473-85
    Maeshima A et al
    2006/01/01
  • 備考:
    Species: Rat, Application: Bioassay, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Farnworth PG et al. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan. Endocrinology 2007 Nov;148(11):5355-68
    Farnworth PG et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: Competitive Binding Assay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kupershmidt L et al. The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases. J. Neurochem. 2007 Nov;103(3):962-71
    Kupershmidt L et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Western Blot Control, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Watanabe K et al. Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor. J. Biol. Chem. 2007 Dec;282(49):35772-86
    Watanabe K et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Wacker I et al. Key role for activin B in cellular transformation after loss of the von Hippel-Lindau tumor suppressor. Mol. Cell. Biol. 2009 Apr;29(7):1707-18
    Wacker I et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Castonguay R et al. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J. Biol. Chem. 2011 Aug;286(34):30034-46
    Castonguay R et al
    2011/01/01
  • 備考:
    Application: Surface Plasmon Resonance, Sample Type: recombinant Endoglin
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Mottershead DG et al. Signalling pathways mediating specific synergistic interactions between GDF9 and BMP15. Mol. Hum. Reprod. 2012 Mar;18(3):121-8
    Mottershead DG et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kadaja M et al. SOX9: a stem cell transcriptional regulator of secreted niche signaling factors. Genes Dev. 2014 Feb;28(4):328-41
    Kadaja M et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Carrancio S et al. An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin. Br. J. Haematol. 2014 Jun;165(6):870-82
    Carrancio S et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Tamminen JA et al. Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. Exp. Cell Res. 2015 Mar;332(1):102-15
    Tamminen JA et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Ungefroren H et al. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
    Ungefroren H et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Kanamori Y et al. Regulation of hepcidin expression by inflammation-induced activin B. Sci Rep 2016 Dec;6:38702
    Kanamori Y et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed